Frederick Finnegan

Rick Finnegan is an industry executive with over 35 years of experience at pharmaceutical/biotech companies ranging in size and complexity from Fortune 500 to pre-IPO start-ups. He has managed programs at all stages of the development; from discovery, through pre-clinical and clinical development as well as all stages of launch and late-stage commercialization, launched 15 brands in 12 therapeutic categories including 4 in orphan diseases. He has overseen commercial and multi-functional organizations in US, Europe, and Japan with combined P&L responsibility ~$150 MM. Significant Investor Relations experience includes IPO/PIPE road shows and presentations at key industry and investor conferences.